Monitoring dynamic interactions between breast cancer cells and human bone tissue in a co-culture model

Molecular Imaging and Biology

Volumn 16, Issue 2, 2014, Pages 158-166

  Contag, Christopher H ^a   Lie, Wen Rong ^b   Bammer, Marie C ^a   Hardy, Jonathan W ^a   Schmidt, Tobi L ^a   Maloney, William J ^a   King, Bonnie L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Millipore   (United States)

Author keywords

Bioluminescence imaging (BLI); Breast cancer metastasis to bone; Ex vivo co culture; Human bone microenvironment; Metastatic niche

Indexed keywords

LUCIFERASE;

ARTICLE; BIOLUMINESCENCE; BONE TISSUE; BREAST CANCER; BREAST CELL; CANCER CELL; CASE REPORT; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; FEMALE; HIP ARTHROPLASTY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ARTHROPLASTY, REPLACEMENT, HIP; BONE AND BONES; BONE MARROW; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; LUMINESCENT MEASUREMENTS; MODELS, BIOLOGICAL; MOLECULAR IMAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 84896392543     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0685-0     Document Type: Article

References (41)

1. Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55:61-66
2. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584-593
3. Goldstein RH, Weinberg RA, Rosenblatt M (2010) Of mice and (wo)men: mouse models of breast cancer metastasis to bone. J Bone Miner Res Off J Am Soc Bone Miner Res 25:431-436
4. Kim IS, Baek SH (2010) Mouse models for breast cancer metastasis. Biochem Biophys Res Commun 394:443-447
5. Kuperwasser C, Dessain S, Bierbaum BE et al (2005) A mouse model of human breast cancer metastasis to human bone. Cancer Res 65:6130-6138
6. Mollard S, Mousseau Y, Baaj Y et al (2011) How can grafted breast cancer models be optimized? Cancer Biol Ther 12:855-864
7. Lim PK, Bliss SA, Patel SA et al (2011) Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 71:1550-1560
8. Oh HS, Moharita A, Potian JG et al (2004) Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells. Cancer Res 64:6327-6336
9. Moharita AL, Taborga M, Corcoran KE et al (2006) SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. Blood 108:3245-3252
10. Koro K, Parkin S, Pohorelic B et al (2011) Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration. Breast Cancer Res Treat 126:73-83
11. Pohorelic B, Singh R, Parkin S et al (2012) Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment. Breast Cancer Res treat 133:201-214
12. Nicola MH, Bizon R, Machado JJ et al (2003) Breast cancer micrometastases: different interactions of carcinoma cells with normal and cancer patients' bone marrow stromata. Clin Exp Metastasis 20:471-479
13. Korah R, Boots M, Wieder R (2004) Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow. Cancer Res 64:4514-4522
14. Martin FT, Dwyer RM, Kelly J et al (2010) Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res treat 124:317-326
15. Rajski M, Vogel B, Baty F et al (2012) Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer. PloS One 7:e29743
16. Krishnan V, Shuman LA, Sosnoski DM et al (2011) Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures. J Cell Physiol 226:2150-2158
17. Bussard KM, Venzon DJ, Mastro AM (2010) Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer. J Cell Biochem 111:1138-1148
18. Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3(Suppl 3):S131-S139
19. Weatherholt AM, Fuchs RK, Warden SJ (2012) Specialized connective tissue: bone, the structural framework of the upper extremity. J Hand Ther Off J Am Soc Hand Ther 25:123-131, quiz 132
20. Thorne SH, Barak Y, Liang W et al (2009) CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy. Mol Cancer Ther 8:333-341
21. Braun S, Pantel K, Muller P et al (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342:525-533
22. Coombes RC, Berger U, Mansi J, et al. (1986) Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer. NCI Monogr (1):51-53
23. Cote RJ, Rosen PP, Lesser ML et al (1991) Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol Off J Am Soc Clin Oncol 9:1749-1756
24. Diel IJ, Kaufmann M, Costa SD et al (1996) Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Nat Cancer Inst 88:1652-1658
25. Gebauer G, Fehm T, Merkle E et al (2001) Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol Off J Am Soc Clin Oncol 19:3669-3674
26. Krishnamurthy S, Cristofanilli M, Singh B et al (2010) Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer 116:3330-3337
27. Karrison TG, Ferguson DJ, Meier P (1999) Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 91:80-85
28. Willis L, Alarcon T, Elia G et al (2010) Breast cancer dormancy can be maintained by small numbers of micrometastases. Cancer Res 70:4310-4317
29. Goss P, Chambers A (2010) Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 10:871-877
30. Guise TA, Mohammad KS, Clines G et al (2006) Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12:6213s-6216s
31. Schiller KR, Zillhardt MR, Alley J, Borjesson DL, Beitz AJ, Mauro LJ (2009) Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model. BMC Cancer 9:45
32. Curtin P, Youm H, Salih E (2012) Three-dimensional cancer-bone metastasis model using ex-vivo co-cultures of live calvarial bones and cancer cells. Biomaterials 33:1065-1078
33. Sosnoski DM, Krishnan V, Kraemer WJ et al (2012) Changes in cytokines of the bone microenvironment during breast cancer metastasis. Int J Breast Cancer 2012:160265
34. Nieman KM, Kenny HA, Penicka CV et al (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17:1498-1503
35. Owen S, Ye L, Sanders AJ, Mason MD, Jiang WG (2013) Expression profile of receptor activator of nuclear-kappaB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. Anticancer Res 33:199-206
36. Uemura H, Yasui T, Kiyokawa M et al (2002) Serum osteoprotegerin/ osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol 174:353-359
37. Fata JE, Kong YY, Li J et al (2000) The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103:41-50
38. Labovsky V, Vallone VB, Martinez LM et al (2012) Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines. Cancer Cell Int 12:29
39. Rachner TD, Benad P, Rauner M et al (2009) Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis. J Cell Biochem 108:106-116
40. Butler JM, Kobayashi H, Rafii S (2010) Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 10:138-146
41. Riccio AI, Wodajo FM, Malawer M (2007) Metastatic carcinoma of the long bones. Am Fam Physician 76:1489-1494